Infigratinib in upper tract urothelial carcinoma vs urothelial carcinoma of the bladder and association with comprehensive genomic profiling/cell-free DNA results.
Year: 2019
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Nazli Dizman, Jonathan E. Rosenberg, Jean H. Hoffman-Censits, David I. Quinn, Daniel Peter Petrylak, Matt D. Galsky, Ulka N. Vaishampayan, Ugo De Giorgi, Sumati Gupta, Howard A. Burris, Harris S. Soifer, Gary Li, Carl L. Dambkowski, Susan Moran, Yining Ye, Siamak Daneshmand, Dean F. Bajorin, Sumanta K. Pal
Institutions: City Of Hope National Medical Center, Memorial Sloan Kettering Cancer Center, Johns Hopkins University, Sidney Kimmel Comprehensive Cancer Center, USC Norris Comprehensive Cancer Center, Yale Cancer Center, Smilow Cancer Hospital, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, Wayne State University, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Huntsman Cancer Institute, University of Utah Health Care, Sarah Cannon, University of Southern California
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2947493479